Physician

Stuart Weinerman, MD

According to 2025 Medicare claims, Stuart Weinerman, MD (NPI: 1376698159) practices endocrinology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is NORTH SHORE-LIJ MEDICAL PC (NPI: 1053688572; TIN: 113506359) and primary practice location at 11021-5310. Weinerman is affiliated with the Northwell Health ACO (ACO ID: A3030), participating under the MSSP model.

Weinerman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,771 traditional Medicare patients, billed 165,008 HCPCS/CPT codes, and received $2,735,364 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,659 prescription claims across 676 beneficiaries totaling $728,466 in drug costs, led by Prolia (Denosumab). DME data shows 88 claims. Open Payments data shows 21 records totaling $11,045. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $530,636 to $2,735,364. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and rose steadily, from $5,337 to $19,938.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,181	31,128	$530,636
2016	1,291	47,090	$796,766
2017	1,360	60,575	$991,299
2018	1,338	64,034	$1,089,311
2019	1,424	69,704	$1,214,488
2020	1,341	76,526	$1,276,149
2021	1,450	91,787	$1,575,942
2022	1,578	110,809	$1,841,479
2023	1,684	138,175	$2,254,914
2024	1,771	165,008	$2,735,364

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	638	2,174	$719,779
2016	541	2,235	$623,241
2017	520	2,076	$731,951
2018	546	2,135	$659,207
2019	565	2,146	$638,966
2020	618	2,315	$669,107
2021	653	2,457	$841,590
2022	691	2,398	$794,651
2023	656	2,518	$877,062
2024	676	2,659	$728,466

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	73	205	$6,757
2016	51	166	$2,593
2017	43	87	$1,590
2018	36	88	$4,132
2019	15	109	$12,787
2020	14	107	$11,735
2021	17	127	$15,134
2022	11	138	$19,289
2023	N/R	131	$19,169
2024	12	88	$18,689

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,048	1,276	$108
77080	Dxa bone density measurement of hip, pelvis, spine	1,051	1,056	$46
J0897	Injection, denosumab, 1 mg	891	90,780	$21
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	757	876	$14
96372	Injection of drug or substance under skin or into muscle	927	1,854	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prolia	Denosumab	120	21,588	$206,013
Tymlos	Abaloparatide	38	1,350	$122,078
Ozempic	Semaglutide	45	2,418	$77,434
Trulicity	Dulaglutide	20	1,210	$39,556
Risedronate Sodium	Risedronate Sodium	354	30,246	$37,413

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	40	$17,983
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	12	28	$661
A4259	Lancets, per box of 100	N	N/R	20	$45

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	21	$11,045	Neurocrine BioSciences Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Stuart Weinerman, MD?

Tedicare shows public-source Medicare data for Stuart Weinerman, MD (NPI 1376698159), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Stuart Weinerman, MD have ACO affiliation data?

Stuart Weinerman, MD is shown with ACO affiliation data for Northwell Health ACO (MSSP, ACO ID A3030).

What billing organization is linked to Stuart Weinerman, MD?

Stuart Weinerman, MD is linked to NORTH SHORE-LIJ MEDICAL PC (billing NPI 1053688572) in the available physician profile data.

Does Stuart Weinerman, MD have Open Payments data?

Stuart Weinerman, MD has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.